1 Imperial College, National Heart & Lung Institute, Royal Brompton Hospital, London, UK 2 Imperial College, National Heart & Lung Institute, Hammersmith Hospital, London, UK Correspondence to: Dr ...

Correspondence to Dr Ninian N Lang, BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow G12 8TA, UK; ...

The optimal treatment of chronic coronary syndromes (CCS) represents to date a matter of debate as revascularisation has not ...

National Heart & Lung Institute, Imperial College of Science, Technology and Medicine, and Royal Brompton and Harefield NHS Trust, London, UK Dr S Y Ho, Paediatrics, National Heart & Lung Institute, ...

Background Limited empirical evidence informs driving restrictions after implantable cardioverter-defibrillator (ICD) ...

Background Cardiovascular disease (CVD) risk increases with age. Statins reduce cardiovascular risk but their effects are less certain at older ages. We assessed the long-term effects and ...

Correspondence to Professor Massimo Imazio, University Cardiology, AOU Città della Salute e della Scienza di Torino, Torino 10126, Italy; massimo_imazio{at}yahoo.it Colchicine is an ancient drug, ...

The practice of cardiology is increasingly constrained by guidelines, regulations, and legal considerations. Cardiologists, like any other group of doctors, have a primary duty of care to individual ...

For patients with heart failure and reduced or mildly reduced left ventricular ejection fraction, iron deficiency is common ...

Department of Cardiology and Radiology, Erasmus Medical Center—Thorax center, Rotterdam, The Netherlands Correspondence to Professor P J de Feyter, Department of Cardiology and Radiology, Erasmus ...

Dan M Roden MD, Director, Division of Clinical Pharmacology, Vanderbilt University School of Medicine, 532C Medical Research Building-I, Nashville, TN 37232-6602, USA ...